Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients – study protocol for a randomized controlled trial
Keyword(s):
Phase Ii
◽
2021 ◽
Vol Volume 14
◽
pp. 1243-1252
2021 ◽
Vol 7
(1)
◽
pp. 17-25